The Enterprise Value as of October 2024 (TTM) for Infinity Pharmaceuticals, Inc. (INFI) is -16386911.00

According to Infinity Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -16386911.00. This represents a change of -202.51% compared to the average of 15.99M of the last 4 quarters.

Infinity Pharmaceuticals, Inc. (INFI) Historical Enterprise Value (quarterly & annually)

How has INFI Enterprise Value performed in the past?

The mean historical Enterprise Value of Infinity Pharmaceuticals, Inc. over the last ten years is 173.69M. The current -16386911.00 Enterprise Value has changed -1043.46% with respect to the historical average. Over the past ten years (40 quarters), INFI's Enterprise Value was at its highest in in the September 2013 quarter at 784.08M. The Enterprise Value was at its lowest in in the June 2016 quarter at -36797707.54.

Infinity Pharmaceuticals, Inc. (INFI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Infinity Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Infinity Pharmaceuticals, Inc. (INFI) Average Enterprise Value

How has INFI Enterprise Value performed in the past?

The current Enterprise Value of Infinity Pharmaceuticals, Inc. (INFI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Infinity Pharmaceuticals, Inc. (INFI) Enterprise Value vs. Peers

How is INFI’s Enterprise Value compared to its peers?

Infinity Pharmaceuticals, Inc.’s Enterprise Value is less than NextCure, Inc. (25.87M), less than Chimerix, Inc. (64.04M), less than Eledon Pharmaceuticals, Inc. (86.05M), less than Kiromic BioPharma, Inc. (10.46M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (59.12M), less than Assembly Biosciences, Inc. (97.39M), less than Instil Bio, Inc. (335.48M), less than Nuvation Bio Inc. (1.07B), less than Generation Bio Co. (219.63M), less than Kronos Bio, Inc. (13.00M), less than Erasca, Inc. (672.18M), less than C4 Therapeutics, Inc. (439.76M), less than Edgewise Therapeutics, Inc. (3.29B), less than Lyra Therapeutics, Inc. (20.08M), less than Trevi Therapeutics, Inc. (214.72M), less than SQZ Biotechnologies Company (24.11M), greater than Protara Therapeutics, Inc. (-46431870.00), less than TRACON Pharmaceuticals, Inc. (-6075769.00), less than Aditxt, Inc. (12.51M), less than NeuroBo Pharmaceuticals, Inc. (-945712.00), less than Dermata Therapeutics, Inc. (-2560986.00), less than Unicycive Therapeutics, Inc. (47.96M), less than Revelation Biosciences, Inc. (-8879083.00),

Build a custom stock screener for Infinity Pharmaceuticals, Inc. (INFI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Infinity Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Infinity Pharmaceuticals, Inc. (INFI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Infinity Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.